Key figures for Sri Lanka — each one is the figure on the page it links to
Life expectancy at birth in Sri Lanka was 77.7 years in 2024. Sri Lanka had a population of 21,756,000 in 2025.
| Indicator | Latest value | Year | Type | All countries |
|---|---|---|---|---|
| Life expectancy | 77.7 years | 2024 | Reported, international agency | By country |
| Population | 21,756,000 | 2025 | Reported, international agency | By country |
| Under-five mortality rate | 5.9 per 1 000 live births | 2024 | Estimate, international agency | By country |
| Infant mortality rate | 5.2 per 1 000 live births | 2024 | Estimate, international agency | By country |
| Fertility rate | 1.95 births per woman | 2024 | Reported, international agency | By country |
| Measles vaccination coverage | 97% | 2025 | Estimate, international agency | By country |
| DTP3 vaccination coverage | 96% | 2025 | Estimate, international agency | By country |
| Health spending per person | US$134 per person | 2023 | Reported, international agency | By country |
The latest year differs by indicator. "Reported" marks a figure published as observed; "Estimate" marks a modelled figure. Each indicator links to its page for Sri Lanka, with every year.
2026 is not over, so every figure is a count so far. At most 8 diseases are shown, from the most reported cases to the fewest. "Counted to" is the date the count runs to; a dash means no date is given here.
| Disease | Cases, 2026 so far | Counted to | All countries |
|---|---|---|---|
| Dengue fever | 93,420 | 6 Sep 2026 | By country |
| Varicella | 8,668 | 6 Sep 2026 | By country |
| Tuberculosis | 5,681 | 6 Sep 2026 | By country |
| Leptospirosis | 5,499 | 6 Sep 2026 | By country |
| Leishmaniasis | 2,840 | – | – |
| Meningitis, unspecified | 2,468 | – | – |
| Leprosy | 832 | 6 Sep 2026 | By country |
| Dysentery, unspecified | 800 | – | – |
ENCLAI. Sri Lanka health profile. https://enclai.net/country/lka/health-profile (accessed 16 November 2026).
The figures on this page are free under CC BY-NC-SA 4.0: credit ENCLAI and the originating authorities; commercial use needs a licence (plans).
One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.